{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021019","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2024-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.933307+00:00","generated_at":"2026-06-01T09:51:41.857091+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biofrontera regains Nasdaq compliance on stockholders' equity rule; future warning","bullets":["May 17, 2024 Nasdaq notice confirms compliance with Rule 5550(b)(1) based on Q1 2024 10-Q.","Prior non-compliance disclosed Nov 2023 due to stockholders' equity deficiency in Q3 2023.","Notice cautions that failure to maintain compliance in next periodic report may result in delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021019","json":"https://secwatch.observer/filing/0001493152-24-021019.json","markdown":"https://secwatch.observer/filing/0001493152-24-021019.md","text":"https://secwatch.observer/filing/0001493152-24-021019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315224021019/0001493152-24-021019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315224021019/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:51:41.857091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}